Congress Asset Management CO Horizon Therapeutics Public LTD CO Transaction History

Congress Asset Management CO

$13.6 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$98.98 - $115.74 $123,230 - $144,096	-1,245 Reduced 10.69%	10,400 $1.2 Million
Q2 2023 Jul 27, 2023	SELL	$96.34 - $112.38 $4.6 Million - $5.37 Million	-47,778 Reduced 80.4%	11,645 $1.2 Million
Q1 2023 Apr 21, 2023	SELL	$107.32 - $113.5 $135 Million - $142 Million	-1,253,712 Reduced 95.47%	59,423 $6.49 Million
Q4 2022 Jan 18, 2023	SELL	$62.39 - $113.8 $15.7 Million - $28.6 Million	-251,611 Reduced 16.08%	1,313,135 $0
Q3 2022 Nov 08, 2022	SELL	$58.92 - $84.67 $1.16 Million - $1.67 Million	-19,699 Reduced 1.24%	1,564,746 $96.8 Million

Q2 2022 Aug 02, 2022	SELL	$79.4 - $116.36 $1.54 Million - $2.26 Million	-19,416 Reduced 1.21%	1,584,445 $126 Million
Q1 2022 Apr 20, 2022	SELL	$86.42 - $109.81 $1.01 Million - $1.28 Million	-11,698 Reduced 0.72%	1,603,861 $169 Million
Q4 2021 Jan 28, 2022	SELL	$98.56 - $119.91 $4.59 Million - $5.58 Million	-46,547 Reduced 2.8%	1,615,559 $174 Million
Q3 2021 Nov 08, 2021	SELL	$91.91 - $110.37 $4.75 Million - $5.71 Million	-51,729 Reduced 3.02%	1,662,106 $182 Million
Q2 2021 Aug 05, 2021	SELL	$86.24 - $95.92 $3.81 Million - $4.24 Million	-44,177 Reduced 2.51%	1,713,835 $160 Million
Q1 2021 May 05, 2021	SELL	$71.83 - $95.48 $6.86 Million - $9.11 Million	-95,445 Reduced 5.15%	1,758,012 $162 Million
Q4 2020 Jan 26, 2021	SELL	$67.0 - $84.39 $1.76 Million - $2.22 Million	-26,273 Reduced 1.4%	1,853,457 $136 Million
Q3 2020 Nov 03, 2020	SELL	$55.23 - $79.93 $4.18 Million - $6.05 Million	-75,654 Reduced 3.87%	1,879,730 $146 Million
Q2 2020 Jul 23, 2020	BUY	$30.2 - $56.98 $51.9 Million - $97.9 Million	1,717,803 Added 723.04%	1,955,384 $109 Million
Q1 2020 Apr 21, 2020	SELL	$24.87 - $38.56 $423,859 - $657,178	-17,043 Reduced 6.69%	237,581 $7.04 Million
Q4 2019 Feb 10, 2020	SELL	$25.43 - $36.67 $278,051 - $400,949	-10,934 Reduced 4.12%	254,624 $9.22 Million
Q3 2019 Nov 01, 2019	SELL	$23.0 - $27.97 $305,624 - $371,665	-13,288 Reduced 4.77%	265,558 $7.23 Million
Q2 2019 Aug 07, 2019	BUY	$22.81 - $28.48 $6.36 Million - $7.94 Million	278,846 New	278,846 $6.71 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Account